GT Biopharma (OXIA.F) Q2 2024 Earnings

15MayConfirmed
Q2 2024
-2.48
-2.15
-1.83
-1.51

Details

Expected EPS
-2.479464
Actual EPS
-1.5060448
Surprise EPS
0.97
Surprise Percent
+39.26%

Description

GT Biopharma (OXIA.F) has reported earnings of -1.5060448 per share for Q2 2024.

0 Comments

Share your thoughts